Delivery Order SPE2DB24D1021-SPE2DB24FEUBZ

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,550.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEOMYC-POLYM-GRAMICID EYE DROP 10ML, a pharmaceutical product, with a completion date of May 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Neomycin-Polymyxin-Dexamethasone eye drops with a ceiling value of $1,392.27. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 for providing a comprehensive range of medical commodities to support military...
The Defense Logistics Agency (DLA) awarded a $9,971.22 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of loteprednol etabonate 0.5% eye drops. This delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to...
The Defense Logistics Agency awarded a $101,240 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561504198, described as NEOMYC-POLYM-DEXAMETH EYE DROP 5ML. The firm fixed price order is being fulfilled under DLA's pharmaceutical supply chain contract vehicle. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery of the requested eye drops to occur between July 14-17, 2023. No set aside designation or...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,564.51 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567039243 ! VEVYE 0.1% EYE DROP 2ML, with a period of performance through January 27, 2025. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,516.76 firm fixed-price delivery order is for the supply of "4564617693 ! MIEBO 100% EYE DROP 3ML", with a completion date of May 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,182.71 firm fixed-price delivery order is for the delivery of a pharmaceutical product, "4566295449 ! XDEMVY 0.25% DROP 10ML", with a completion date of November 22, 2024. The contract does not have a set-aside designation, indicating it was open to competition. Amerisourcebergen holds a significant...
The Defense Logistics Agency awarded a $809.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562071030 NEOMYC-POLYM-GRAMICID EYE DROP 10ML. The place of performance is Conshohocken, Pennsylvania. The period of performance is September 6-7, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense, procuring a wide range of medical supplies and pharmaceuticals to support military readiness and...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,182.71 firm fixed price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4565454944 ! XDEMVY 0.25% DROP 10ML pharmaceutical products. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to support military treatment programs and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $1,182.71, is a delivery order for the provision of a specific pharmaceutical product - "4564933195 ! XDEMVY 0.25% DROP 10ML". The contract is a firm fixed price award with no set-aside designation, indicating full and open competition. Amerisourcebergen holds a...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB24FEUBZ
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,022.34 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide 4565803453 NEOMYC-POLYM-DEXAMETH EYE DROP 5ML. This award is a part of DLA's larger indefinite delivery contract (IDC) valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for Amerisourcebergen to deliver a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The DLA IDC does not have a set-aside designation, and Amerisourcebergen has also been awarded an IDC valued at up to $750,000 through May 2024 by the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 12/13/24, 9:29 AM